The following is a summary of "Transit time flow management as a management strategy in high-risk groups undergoing coronary ...

Compared with other studies, the differences in outcomes between percutaneous coronary intervention (PCI) and coronary artery ...

Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) announced today they have entered a non-binding Memorandum of ...

aDivision of Cardiac Surgery, Schulich Heart Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON M4N 3M5, Canada ...

In sharp contrast to earlier studies, patients with severe triple-vessel heart disease fared equally well whether they ...

STATEN ISLAND, N.Y. — Northwell Staten Island University Hospital (SIUH) in Ocean Breeze has been recognized with the highest ...

Coronary artery bypass grafting is a more invasive procedure where surgeons use blood vessels from another part of the body ...

The Germany-based Journal of Cardiothoracic Surgery say it is a serious complication with a low survival rate..Manoj ...

More information: Derrick Y Tam et al, Fractional flow reserve-guided percutaneous coronary intervention versus coronary artery bypass grafting: please mind the gap, The Lancet (2025). DOI: 10. ...

Q4 2024 Earnings Call Transcript March 31, 2025 Cytosorbents Corporation beats earnings expectations. Reported EPS is $-0.03, ...

FDA Approval: The FDA granted full approval for Symvess on December 19, 2024 for use in adults as a vascular conduit for extremity arterial injury when urgent revascularization is needed to avoid ...